1. Role of concurrent chemoradiotherapy and stereotactic body radiation treatment for palliation of previously untreated head and neck cancers
- Author
-
Teessa Perekattu Kuruvilla, Toms Vengaloor Thomas, Satyaseelan Packianathan, Eswar K. Mundra, Sanjay Joseph, Hiba Z Ahmed, Eldrin Bhanat, and Srinivasan Vijayakumar
- Subjects
medicine.medical_specialty ,business.industry ,R895-920 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,incurable head and neck cancer ,stereotactic ablative radiotherapy for palliation ,Concurrent chemoradiotherapy ,Medical physics. Medical radiology. Nuclear medicine ,Oncology ,stereotactic body radiation treatment for palliation ,Medicine ,Stereotactic body radiation ,metastatic head and neck cancer ,Radiology ,business ,Head and neck ,palliative chemoradiation ,RC254-282 - Abstract
Palliative concurrent chemoradiotherapy has not been well evaluated for patients who are not a candidate for definitive treatment. Even though stereotactic radiotherapy has established a role in the re‐irradiation of recurrent head and neck tumors, its role is not established as a possible primary treatment modality for patients who are not eligible for curative treatment. This article reviews the available literature on the role of chemoradiotherapy and stereotactic radiation for palliation of previously untreated head and neck cancers.
- Published
- 2020
- Full Text
- View/download PDF